EDGAR Filing Documents for 0001640334-17-001571

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001640334-17-001571

Filing Date

2017-08-08

Accepted

2017-08-08 17:22:18

Documents

Period of Report

2017-08-04

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	nymox_6k.htm	6-K	8581
2	QUARTERLY REPORT	nymox_ex991.htm	EX-99.1	236034
3	CEO CERTIFICATIONS	nymox_ex992.htm	EX-99.2	11087
4	CFO CERTIFICATIONS	nymox_ex993.htm	EX-99.3	11142
5		nymox_ex991img2.jpg	GRAPHIC	5506
	Complete submission text file	0001640334-17-001571.txt		275605

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 171015742
SIC: 2835 In Vitro & In Vivo Diagnostic Substances